Literature DB >> 20713773

Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.

Yi-Chun Chen1, Hsien-Ching Chiu, Chia-Yu Chu.   

Abstract

OBJECTIVE: To investigate the clinical and pathologic features of patients with drug reaction with eosinophilia and systemic symptoms (DRESS) in Taiwan.
DESIGN: Case series and retrospective analysis.
SETTING: A medical referral center in Northern Taiwan. PATIENTS: Sixty cases of DRESS occurring from June 1998 to May 2008. MAIN OUTCOME MEASURES: Clinical characteristics for specific drugs and important prognostic factors in DRESS.
RESULTS: Patients ranged in age from 6 to 90 years (mean age, 51 years). The female to male ratio was 1.3 to 1. The most common culprit drugs were allopurinol, phenytoin, and dapsone. Exanthematous eruption was the most common skin manifestation, but purpurae and blisters were also observed. Hepatic (80%), renal (40%), and pulmonary (33%) involvement were also common. The overall mortality rate was 10%. Allopurinol-induced DRESS was characterized by preceding chronic renal insufficiency and frequent renal involvement. Pancytopenia indicated a poor prognosis.
CONCLUSIONS: Drug reaction with eosinophilia and systemic symptoms has a variable clinical presentation, and its definition requires clarification. It may be a heterogeneous syndrome with some particular patterns related to different drugs. Early diagnosis and prompt discontinuation of offending drug regimens are essential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713773     DOI: 10.1001/archdermatol.2010.198

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  49 in total

1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

2.  Severe drug-induced skin and liver injury from rivaroxaban.

Authors:  Patrick Barrett; Raj Vuppalanchi; Howard Masuoka; Naga Chalasani
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

3.  Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.

Authors:  Solène M Laville; Bénédicte Stengel; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2019-04-13       Impact factor: 4.335

Review 4.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

5.  A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Glimepiride, the Unlikely Culprit.

Authors:  Nishanth Dev
Journal:  Maedica (Buchar)       Date:  2018-06

6.  Immune-mediated reactions to vancomycin: A systematic case review and analysis.

Authors:  Jasmit S Minhas; Paige G Wickner; Aidan A Long; Aleena Banerji; Kimberly G Blumenthal
Journal:  Ann Allergy Asthma Immunol       Date:  2016-05-04       Impact factor: 6.347

7.  Evaluation of Cyclosporine for the Treatment of DRESS Syndrome.

Authors:  Emily Nguyen; Daniel Yanes; Sotonye Imadojemu; Daniela Kroshinsky
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

Review 8.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

9.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.

Authors:  Anna R Wolfson; Li Zhou; Yu Li; Neelam A Phadke; Ohn A Chow; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2018-08-31

10.  DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?

Authors:  Zahrae Sandouk; Zaid Alirhayim; Dania Khoulani; Syed Hassan
Journal:  BMJ Case Rep       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.